Skip to content
BLACK BOOK
manufacturer✓ Verified☎ Contact on file

Lyell Immunopharma, Inc.

Pharmaceutical Preparations · South San Francisco, CA, United States

  1. PrincipalsDavid ShookChief Medical OfficerGary K. LeeChief Scientific OfficerLynn SeelyPresident and CEOand 4 more
  2. CompanyLyell Immunopharma, Inc.South San Francisco, CA, United States
  3. Phone line+1 (650) 695-0677General business
Request a quote

Lyell Immunopharma, Inc. is an SEC-registered Nasdaq-listed company (ticker LYEL) classified under SIC 2834: Pharmaceutical Preparations.

Capabilities

✓ Pharmaceutical manufacturing
Evidence for each capability
  • Pharmaceutical manufacturing. SIC 2834 — Pharmaceutical Preparations — SEC EDGAR company submissions

People 7

Chief executive

Lynn SeelyPresident and CEO

Finance

Veronica Sanchez BulisVP, Corporate Controller

Operations

Stephen J. HillChief Operating Officer

Legal

Mark A MeltzGeneral Counsel
Everyone else on file (3)
David ShookChief Medical Officer
Gary K. LeeChief Scientific Officer
Smital ShahChief Fin. and Bus. Officer

Supplier profile

Production
Yes

Source timeline

  1. Record created from SEC EDGAR company submissions

    SEC EDGAR company submissions ↗
  2. Smital Shah — Chief Fin. and Bus. Officer

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
  3. David Shook — Chief Medical Officer

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
  4. Gary K. Lee — Chief Scientific Officer

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗

Similar makers